PAVmed (NASDAQ:PAVM) Share Price Passes Below Fifty Day Moving Average – Here’s What Happened

PAVmed Inc. (NASDAQ:PAVM) shares passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.71 and traded as low as $0.64. PAVmed shares last traded at $0.68, with a volume of 62,629 shares traded.

PAVmed Trading Down 0.3 %

The stock has a market capitalization of $11.59 million, a price-to-earnings ratio of -0.16 and a beta of 1.13. The stock has a fifty day moving average of $0.71 and a two-hundred day moving average of $0.83.

Institutional Trading of PAVmed

An institutional investor recently raised its position in PAVmed stock. First Manhattan CO. LLC. grew its position in PAVmed Inc. (NASDAQ:PAVM) by 16.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 700,000 shares of the company’s stock after buying an additional 100,000 shares during the period. First Manhattan CO. LLC. owned approximately 6.32% of PAVmed worth $439,000 at the end of the most recent quarter. 19.93% of the stock is currently owned by institutional investors.

About PAVmed

PAVmed Inc focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck.